(Q39251183)

10 September 2017

title

Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules (English)

1 reference

10 September 2017

1 reference

C Hawkey

1

1 reference

10 September 2017

I Burnett

2

1 reference

10 September 2017

M S Gold

3

1 reference

10 September 2017

K Garsed

4

1 reference

10 September 2017

D Stevenson

5

1 reference

10 September 2017

J Mannath

6

1 reference

10 September 2017

A Norman

7

1 reference

10 September 2017

V Shepherd

8

1 reference

10 September 2017

V Subramanian

9

1 reference

10 September 2017

R D Johnston

10

1 reference

10 September 2017

M Brown

11

1 reference

10 September 2017

language of work or name

English

0 references

publication date

28 February 2012

1 reference

Alimentary Pharmacology & Therapeutics

10 September 2017

published in

1 reference

10 September 2017

volume

35

1 reference

10 September 2017

issue

7

1 reference

10 September 2017

page(s)

819-827

1 reference

A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

A review of the gastrointestinal safety data--a gastroenterologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment--findings from the Therapeutic Arthritis Research and Gastrointestina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: An integrated study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

Systematic review: ulcer definition in NSAID ulcer prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2012.05030.X

10.1111/J.1365-2036.2012.05030.X

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference